Journal: PLoS ONE

Article Title: Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

doi: 10.1371/journal.pone.0209204

Figure Lengend Snippet: Reference values for G6PD activity among confirmed dengue paediatric patients.

Article Snippet: Normal and deficient G6PD controls (Cat no PD 2617 for deficient and Cat no PD 2618 for normal, Randox Laboratories Ltd., Crumlin, UK) were used.

Techniques: Activity Assay

Journal: PLoS ONE

Article Title: Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

doi: 10.1371/journal.pone.0209204

Figure Lengend Snippet: Prevalence of G6PD among confirmed dengue paediatric patients according to WHO classification.

Article Snippet: Normal and deficient G6PD controls (Cat no PD 2617 for deficient and Cat no PD 2618 for normal, Randox Laboratories Ltd., Crumlin, UK) were used.

Techniques:

Journal: PLoS ONE

Article Title: Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

doi: 10.1371/journal.pone.0209204

Figure Lengend Snippet: G6PD genotyping in paediatric patients with confirmed dengue.

Article Snippet: Normal and deficient G6PD controls (Cat no PD 2617 for deficient and Cat no PD 2618 for normal, Randox Laboratories Ltd., Crumlin, UK) were used.

Techniques: Activity Assay, Mutagenesis

Journal: PLoS ONE

Article Title: Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

doi: 10.1371/journal.pone.0209204

Figure Lengend Snippet: Phenotype distribution among males and females with G6PD gene mutation according to WHO classification.

Article Snippet: Normal and deficient G6PD controls (Cat no PD 2617 for deficient and Cat no PD 2618 for normal, Randox Laboratories Ltd., Crumlin, UK) were used.

Techniques: Mutagenesis

Journal: PLoS ONE

Article Title: Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

doi: 10.1371/journal.pone.0209204

Figure Lengend Snippet: G6PD status related to severe and non-severe dengue among confirmed dengue paediatric patients.

Article Snippet: Normal and deficient G6PD controls (Cat no PD 2617 for deficient and Cat no PD 2618 for normal, Randox Laboratories Ltd., Crumlin, UK) were used.

Techniques: Activity Assay, Mutagenesis

Journal: PLoS ONE

Article Title: Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

doi: 10.1371/journal.pone.0125796

Figure Lengend Snippet: An outline comparing some common factors of importance between the methods used for G6PD screening in the study.

Article Snippet: The CareStart G6PD deficiency RDT and Trinity Quantitative methods were controlled with two levels of commercially prepared G6PD quality control (QC) (normal level, Cat. No. PD 2618 and deficient level Cat. No. PD 2617 controls) samples from Randox.

Techniques:

Journal: PLoS ONE

Article Title: Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

doi: 10.1371/journal.pone.0125796

Figure Lengend Snippet: Performance of the CareStart G6PD deficiency RDT kit to other commercially available methods for screening G6PD deficiency .

Article Snippet: The CareStart G6PD deficiency RDT and Trinity Quantitative methods were controlled with two levels of commercially prepared G6PD quality control (QC) (normal level, Cat. No. PD 2618 and deficient level Cat. No. PD 2617 controls) samples from Randox.

Techniques:

Journal: PLoS ONE

Article Title: Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

doi: 10.1371/journal.pone.0125796

Figure Lengend Snippet: Diagnostic performance of CareStart G6PD RDT by gender compared to Trinity Biotech Quantitative and Qualitative methods for G6PD deficiency screening.

Article Snippet: The CareStart G6PD deficiency RDT and Trinity Quantitative methods were controlled with two levels of commercially prepared G6PD quality control (QC) (normal level, Cat. No. PD 2618 and deficient level Cat. No. PD 2617 controls) samples from Randox.

Techniques: Diagnostic Assay

Journal: PLoS ONE

Article Title: Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

doi: 10.1371/journal.pone.0125796

Figure Lengend Snippet: Area under the Receiver Operator Characteristics (ROC) curve for G6PD RDT performance considering malaria status of participants.

Article Snippet: The CareStart G6PD deficiency RDT and Trinity Quantitative methods were controlled with two levels of commercially prepared G6PD quality control (QC) (normal level, Cat. No. PD 2618 and deficient level Cat. No. PD 2617 controls) samples from Randox.

Techniques:

Journal: PLoS ONE

Article Title: Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa

doi: 10.1371/journal.pone.0125796

Figure Lengend Snippet: Estimates of G6PD enzyme activity levels by malaria parasite status.

Article Snippet: The CareStart G6PD deficiency RDT and Trinity Quantitative methods were controlled with two levels of commercially prepared G6PD quality control (QC) (normal level, Cat. No. PD 2618 and deficient level Cat. No. PD 2617 controls) samples from Randox.

Techniques: Activity Assay

Journal: The journal of physiological sciences : JPS

Article Title: The distribution of eukaryotic initiation factor 4E after bouts of resistance exercise is altered by shortening of recovery periods.

doi: 10.1186/s12576-020-00781-y

Figure Lengend Snippet: Fig. 3 Protein expression of eIF4F components after three bouts of resistance exercise. Protein expression of eIF4E (a), eIF4G (b), eIF4A (c), and representative bands (d). Data are expressed relative to the Control as the mean ± SE

Article Snippet: Membranes were blocked in 5% skim milk in Tris-buffered saline with Tween 20 (TBST) for 1 h at room temperature and subsequently incubated overnight at 4 °C with the following primary antibodies: p-p70S6K (Thr389, #9205; CST), p70S6K (#2708; CST), p-rpS6 (Ser240/244, #2215; CST), rpS6 (#2217; CST), p-4EBP1 (Thr37/46, #9459; CST), 4EBP1 (#9644; CST), eIF4E (#2067; CST), eIF4G (#2617; CST), eIF4A (#2013; CST), eIF4H (#3469; CST), p-eEF2 (Thr56, #2331; CST), eEF2 (#2332; CST), p-eIF4B (Ser422, #3591; CST), eIF4B (#3592, CST), p-eIF2α (Ser51, #3597; CST), and eIF2α (#5324; CST).

Techniques: Expressing, Control

Journal: The journal of physiological sciences : JPS

Article Title: The distribution of eukaryotic initiation factor 4E after bouts of resistance exercise is altered by shortening of recovery periods.

doi: 10.1186/s12576-020-00781-y

Figure Lengend Snippet: Fig. 4 Distribution of eIF4E after three bouts of resistance exercise. Protein expression of 4EBP1 associated with eIF4E (a), eIF4G associated with eIF4E (b), and representative bands (c). Data are expressed relative to the Control as the mean ± SE. *P < 0.05 vs. Control, †P < 0.05 vs. 72H group, ‡P < 0.05 vs. 24H group

Article Snippet: Membranes were blocked in 5% skim milk in Tris-buffered saline with Tween 20 (TBST) for 1 h at room temperature and subsequently incubated overnight at 4 °C with the following primary antibodies: p-p70S6K (Thr389, #9205; CST), p70S6K (#2708; CST), p-rpS6 (Ser240/244, #2215; CST), rpS6 (#2217; CST), p-4EBP1 (Thr37/46, #9459; CST), 4EBP1 (#9644; CST), eIF4E (#2067; CST), eIF4G (#2617; CST), eIF4A (#2013; CST), eIF4H (#3469; CST), p-eEF2 (Thr56, #2331; CST), eEF2 (#2332; CST), p-eIF4B (Ser422, #3591; CST), eIF4B (#3592, CST), p-eIF2α (Ser51, #3597; CST), and eIF2α (#5324; CST).

Techniques: Expressing, Control